Surgical Innovations Group PLC
30 July 2003
Surgical Innovations Group plc
Additional Listing
30 July 2003
The directors of Surgical Innovations Group plc announce that they have made an
application for 250,000 new ordinary shares of 1p to be admitted to trading on
the AIM. These ordinary shares have been issued for cash at a price of 2p per
share. Dealings are expected to commence on 5 August 2003.
Enquiries:
Surgical Innovations Group
Graham Bowland, Finance Director Tel: +44 (0) 113 230 7597
David Simmons Tel: +44 (0) 161 214 6540
Brown, Shipley & Co. Limited
This information is provided by RNS
The company news service from the London Stock Exchange
AUMUPWGMU
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.